MY17

Overview

MY17 is an inhibitor of protein tyrosine phosphatase 1B ( PTP1B ) ( IC 50 =0.41±0.05 μM). MY17 alleviates palmitic acid (PA) -induced insulin resistance by up-regulating the expression of phosphorylated insulin receptor substrate (IRS1) and protein kinase B ( AKT ). By binding with PTP1B , MY17 can inhibit the activity of PTP1B , thereby improving insulin signaling and having anti-diabetic activity. MY17 can be used in the study of type 2 diabetes.

Application

Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > Phosphatase

Product Information

• Catalog No.: HY-162499
• CAS No.: 3058650-79-3
• Molecular Formula: C21H13N5O3S3
• Molecular Weight: 479.55
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source